Skip to main content
. 2023 Aug 2;27(4):358–367. doi: 10.1177/12034754231188444

Figure 3.

Figure 3

Pooled prevalence of ISRs in randomized controlled trials investigating Certolizumab Pegol. IV = inverse variance; CI = confidence interval.